Merrimack Pharmaceuticals, Inc. (MACK) Social Stream
Merrimack Pharmaceuticals Inc (MACK) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Merrimack Pharmaceuticals Inc.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued January 2, 2019
MACK Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MACK as an investment opportunity.
- MACK has a greater number of analysts covering the stock than practically none of all US stocks.
- Merrimack Pharmaceuticals Inc's variance in analysts' estimates is lower than almost 100% of all US stocks.
- The upside potential (average analyst target price relative to current price) of MACK is greater than 4.07% of Pharmaceutical Products stocks.
- MACK has a greater average analyst price target than 4.49% of Pharmaceutical Products stocks.
Is MACK a Buy, Hold or Sell? See the POWR Ratings now!